U.S. consumers might not always suffer. But any company in the U.S., including small and large retail stores, will increasingly be competing in a new B2C digital model that connects American consumers directly to China.
A new round of Congressional legislation targets China. Will they pass? And when they do, will the government take action, or issue endless reviews and investigations as China marches on, and America risks stalling out post-pandemic.
CPA sent the following to U.S. Senators Rob Portman (R-OH), Tom Carper (D-DE), and 38 other members of the Senate regarding their recent letter to Ambassador Tai asking her to renew expired expiring China Section 301 tariff exclusions. In the letter, CPA urges the Senators to reconsider their support for renewing 301 exclusions, an action…
President Biden said that his climate change policies will create millions of jobs if he favors American manufacturing. If not, any sort of green new deal just ends up being a China job’s program. Here’s China’s position in global wind and solar manufacturing today.
Yellen takes a pass on calling Vietnam, others, currency manipulators. That puts the onus on Commerce and the USTR to do something about it. Will they?
Worried about climate change, Senator Wyden and the Democrats want to give cleantech and energy companies permanent tax breaks. He faces some serious opposition.
McKinsey has turned the corner on the Asia-centric model of globalization. It’s a “now-or-never” moment for US manufacturing. Here’s where CPA sees eye-to-eye.
From retail investors in China ETFs, to Wall Street’s largest investment firms, China’s new technologies can always count on tens of millions of dollars of inflows from Americans. What do we get in return?
By Michael Stumo American workers pay personal income taxes to the governments of states they work in. But corporations often avoid paying corporate taxes on the profits from earnings in the United States. That’s because multinational corporations and their army of lawyers find imaginative ways to make it appear that an embarrassingly large share of…
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.